Jin Ying Song
Directeur/Bestuurslid bij Jiangsu Vanguard Pharmaceutical Co., Ltd.
Profiel
Jin Ying Song is a Member-Supervisory Board at Jiangsu Vanguard Pharmaceutical Co., Ltd.
since 2018.
Ms. Song completed an undergraduate degree at Jiangsu University of Technology.
Actieve functies van Jin Ying Song
| Bedrijven | Functie | Begin |
|---|---|---|
Jiangsu Vanguard Pharmaceutical Co., Ltd.
 Jiangsu Vanguard Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Jiangsu Vanguard Pharmaceutical Co., Ltd. engages in the research, development, production and sale of chemical drugs and proprietary Chinese medicines. Its products include valsartan hydrochlorothiazide tablets, calcium dobesilate capsules, calcium carbonate D3 chewable tablets, irbesartan hydrochlorothiazide tablets, bezafibrate dispersible tablets, aluminum magnesium carbonate chewable tablets, amlodipine maleate dispersible tablets, brucei seed oil soft capsules. The company was founded by Guang Xue He on November 28, 2003 and is headquartered in Nantong, China. | Directeur/Bestuurslid | 01-05-2018 |
Opleiding van Jin Ying Song
| Jiangsu University of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Jiangsu Vanguard Pharmaceutical Co., Ltd.
Jiangsu Vanguard Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Jiangsu Vanguard Pharmaceutical Co., Ltd. engages in the research, development, production and sale of chemical drugs and proprietary Chinese medicines. Its products include valsartan hydrochlorothiazide tablets, calcium dobesilate capsules, calcium carbonate D3 chewable tablets, irbesartan hydrochlorothiazide tablets, bezafibrate dispersible tablets, aluminum magnesium carbonate chewable tablets, amlodipine maleate dispersible tablets, brucei seed oil soft capsules. The company was founded by Guang Xue He on November 28, 2003 and is headquartered in Nantong, China. | Health Technology |
